Sponsor Pipeline

Braveheart Bio, Inc. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
1
Active Trials
0
Recruiting
1
Phase 3
What Changed in the Last 30 Days
First PostedNew Trial FilingPhaseStatus
2026-08-10 NCT07755904 BHB-1893 Versus Metoprolol for Symptomatic Obstructive Hypertrophic Cardiomyopathy Phase 3 Not Yet Recruiting
Active Trials by Phase
Phase 3
1
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT07755904 BHB-1893 Versus Metoprolol for Symptomatic Obstructive Hypertrophic Cardiomyopathy Cardiomyopathy, Hypertrophic Obstructive Not Yet Recruiting
Get alerts when Braveheart Bio, Inc.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free